The Leadership Team at SalioGen Therapeutics drives the strategic direction and operational excellence of the company, overseeing critical functions such as research and development, manufacturing, and intellectual property management. By leveraging their diverse expertise in genome engineering and gene therapy, they collaborate to enhance the EDIT platform, ensuring the advancement of innovative, non-viral gene therapies that aim to deliver transformative patient outcomes.
View all